Pretreatment with lipopolysaccharide ameliorates Pseudomonas exotoxin A-induced hepatotoxicity in rats

References

• Mathurin P, Deng QG, Keshavarzian A, et al. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 2000; 32:1008–017
   PubMed Web of Science ®Google Scholar
• Rao R. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 2009;50:638–44
   PubMed Web of Science ®Google Scholar
• Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885–91
   PubMed Web of Science ®Google Scholar
• Chiu CC, Huang YT, Chuang HL, et al. Coexposure of lipopolysaccharide and Pseudomonas aeruginosa exotoxin A-induced multiple organ injury in rats. Immunopharmacol Immunotoxicol 2009;31:75–82
   PubMed Web of Science ®Google Scholar
• Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979;76:5939–43
   PubMed Web of Science ®Google Scholar
• Liu MY, Cheng YJ, Chen CK, Yang BC. Coexposure of lead- and lipopolysaccharide-induced liver injury in rats: involvement of nitric oxide-initiated oxidative stress and TNF-alpha. Shock 2005;23:360–4
   PubMed Web of Science ®Google Scholar
• Schümann J, Bluethmann H, Tiegs G. Synergism of Pseudomonas aeruginosa exotoxin A with endotoxin, superantigen, or TNF results in TNFR1- and TNFR2-dependent liver toxicity in mice. Immunol Lett 2000;74:165–72
   PubMed Web of Science ®Google Scholar
• Liu J, Sendelbach LE, Parkinson A, Klaassen CD. Endotoxin pretreatment protects against the hepatotoxicity of acetaminophen and carbon tetrachloride: role of cytochrome P450 suppression. Toxicology 2000;147:167–76
   PubMed Web of Science ®Google Scholar
• Nishikage T, Seki S, Toyabe S, et al. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis. J Hepatol 1999;31:18–26
   PubMed Web of Science ®Google Scholar
• Yu Z, Otsuka H, Yamaguchi K, et al. Roles of platelets and macrophages in the protective effects of lipopolysaccharide against concanavalin A-induced murine hepatitis. Biochim Biophys Acta 2011;1812:1069–79
   PubMed Web of Science ®Google Scholar
• Hewett JA, Schultze AE, VanCise S, Roth RA. Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab Invest 1992;66:347–61
   PubMed Web of Science ®Google Scholar
• Hatano M, Sasaki S, Ohata S, et al. Effects of Kupffer cell-depletion on concanavalin A-induced hepatitis. Cell Immunol 2008;251:25–30
   PubMed Web of Science ®Google Scholar
• Cao Q, Batey R, Pang G, et al. IL-6, IFN-γ and TNF-α production by liver-associated T cells and acute liver injury in rats administered concanavalin A. Immunol Cell Biol 1998;76:542–9
   PubMed Web of Science ®Google Scholar
• Colletti LM, Remick DG, Campbell Jr DA. LPS pretreatment protects from hepatic ischemia/reperfusion. J Surg Res 1994;57:337–43
   PubMed Web of Science ®Google Scholar
• Hirohashi N, Morrison DC. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect Immunol 1996;64:1011–15
   PubMed Web of Science ®Google Scholar
• Zhong J, Deaciuc IV, Burikhanov R, de Villiers WJ. Lipopolysaccharide-induced liver apoptosis is increased in interleukin-10 knockout mice. Biochim Biophys Acta 2006;1762:468–77
   PubMed Web of Science ®Google Scholar
• Laithwaite JE, Benn SJ, Yamate J, et al. Enhanced macrophage resistance to Pseudomonas exotoxin A is correlated with decreased expression of the low-density lipoprotein receptor-related protein. Infect Immunol 1999;67:5827–33
   PubMed Web of Science ®Google Scholar
• Schümann J, Angermüller S, Bang R, et al. Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF. J Immunol 1998;161:5745–54
   PubMed Web of Science ®Google Scholar
• Chiu CC, Chen HH, Chuang HL, et al. Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity: an animal model in rat. J Vet Med Sci 2009;71:1–8
   PubMed Web of Science ®Google Scholar
• Zehavi-Willner T, Barneam A, Pinto M. In vivo protective effect of lipopolysaccharide against Pseudomonas aeruginosa exotoxin A in mice. Infect Immun 1991;59:1667–72
   PubMed Web of Science ®Google Scholar
• Chuang HL, Chiu CC, Chen TH, et al. Different bacteria species lipopolysaccharide co-exposure with Pseudomonas exotoxin A on multiple organ injury induction. Immunopharmacol Immunotoxicol 2009;31:616–24
   PubMed Web of Science ®Google Scholar
• Murphey ED, Fang G, Varma TK, Sherwood ER. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-γ. Shock 2007;27:289–95
   PubMed Web of Science ®Google Scholar
• Shimizu S, Yamada Y, Okuno M, et al. Liver injury induced by lipopolysaccharide is mediated by TNFR-1 but not by TNFR-2 or Fas in mice. Hepatol Res 2005;31:136–42
   PubMed Web of Science ®Google Scholar
• Biburger M, Tiegs G. α-Galactosylceramide-induced liver injury in mice is mediated by TNF-α but independent of Kupffer cells. J Immunol 2005;175:1540–50
   PubMed Web of Science ®Google Scholar
• Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196–203
   PubMed Web of Science ®Google Scholar
• Thompson K, Maltby J, Fallowfield J, et al. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology 1998;28:1597–606
   PubMed Web of Science ®Google Scholar
• Teoh N, Field J, Farrell G. Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice. J Hepatol 2006;45:20–7
   PubMed Web of Science ®Google Scholar
• Yamada I, Goto T, Takeuchi S, et al. Mao (Ephedra sinica Stapf) protects against D-galactosamine and lipopolysaccharide-induced hepatic failure. Cytokine 2008;41:293–301
   PubMed Web of Science ®Google Scholar
• Taki-Eldin A, Zhou L, Xie HY, Zheng SS. Liver regeneration after liver transplantation. Eur Surg Res 2012;48:139–53
   PubMed Web of Science ®Google Scholar
• Barton BE, Jackson JV. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immunol 1993;61:1496–9
   PubMed Web of Science ®Google Scholar
• Klein C, Wüstefeld T, Assmus U, et al. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J Clin Invest 2005;115:860–9
   PubMed Web of Science ®Google Scholar
• Tominaga K, Saito S, Matsuura M, Nakano M. Lipopolysaccharide tolerance in murine peritoneal macrophages induces downregulation of the lipopolysaccharide signal transduction pathway through mitogen-activated protein kinase and nuclear factor-kappaB cascades, but not lipopolysaccharide-incorporation steps. Biochim Biophys Acta 1999;1450:130–44
   PubMed Web of Science ®Google Scholar
• Hafenrichter DG, Roland CR, Mangino MJ, Flye MW. The Kupffer cell in endotoxin tolerance: mechanisms of protection against lethal endotoxemia. Shock 1994;2:251–6
   PubMed Web of Science ®Google Scholar
• Sewnath ME, Van Der Poll T, Van Noorden CJ, et al. Endogenous interferon gamma protects against cholestatic liver injury in mice. Hepatology 2002;36:1466–77
   PubMed Web of Science ®Google Scholar
• Gallucci RM, Simeonova PP, Toriumi W, Luster MI. TNF-alpha regulates transforming growth factor-alpha expression in regenerating murine liver and isolated hepatocytes. J Immunol 2000;164:872–8
   PubMed Web of Science ®Google Scholar
• Shi DW, Zhang J, Jiang HN, et al. LPS pretreatment ameliorates multiple organ injuries and improves survival in a murine model of polymicrobial sepsis. Inflamm Res 2011;60:841–9
   PubMed Web of Science ®Google Scholar
• Coats SR, Pham TT, Bainbridge BW, et al. MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex. J Immunol 2005;175:4490–8
   Web of Science ®Google Scholar